バイオフォトニクス市場：用途別、最終用途別-2025～2030年の世界予測

バイオフォトニクス市場は、2023年に579億1,000万米ドルと評価され、2024年には631億4,000万米ドルに達すると予測され、CAGR 9.12％で成長し、2030年には1,067億1,000万米ドルになると予測されています。

バイオフォトニクスは、生物材料の研究に光ベースの技術を応用する学際的なセグメントです。生体組織を分子・細胞レベルで分析、画像化、操作するためのフォトニックデバイスや技術の開発・利用を含みます。フォトニクスの必要性は、非侵襲的、高解像度、高精度な診断・治療ソリューションを提供し、医療研究、診断、治療を大きく前進させるその能力から生じています。主要用途としては、光コヒーレンストモグラフィー、顕微鏡、分光法などのイメージングシステムがあり、これらは病気の早期発見、個別化医療、低侵襲治療において重要な役割を果たします。主要最終用途セグメントは、医療、製薬、バイオテクノロジー、環境モニタリングであり、医療は、先進的診断手順や治療に対する需要の高まりによる主要牽引役です。

市場成長に関しては、技術の進歩、政府研究費の増加、早期疾患発見技術に対する意識の高まりが影響しています。慢性疾患の増加と世界人口の高齢化は、革新的な診断・治療ソリューションの需要をさらに高めています。非接触型医療ソリューションの必要性を強調する最近の世界の健康危機に後押しされ、遠隔医療や遠隔診断の用途拡大に潜在的なビジネス機会があります。しかし、高額な機器、複雑な規制要件、熟練した専門家の不足といった課題が大きな障害となっています。さらに、急速な技術進化により、研究開発への絶え間ない投資が必要となり、中小企業にとっては経営資源が逼迫する可能性があります。

バイオフォトニクスにおけるイノベーションは、費用対効果の高いポータブル診断ツールや、データ分析と予測診断を強化するための人工知能との統合に向けることができます。また、潜在的な成長セグメントとして、ナノスケールイメージングや低侵襲の光学バイオセンサーも検討すべきです。学術界と産業界のコラボレーションにより、技術の進歩が促進される可能性があります。市場情勢はダイナミックで急成長しており、激しい研究開発活動と進化する技術パラダイムが特徴です。企業は、新たな技術に投資し、学際的なコラボレーションを促進し、医療プロバイダーや患者の特定のニーズに合わせてソリューションを調整することで、競合を維持することができます。

市場力学：急速に進化するバイオフォトニクス市場の主要市場洞察を公開

バイオフォトニクス市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネス機会の獲得に備えることができます。こうした動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 高齢者の増加
  • 新しい光音響トモグラフィ（PAT）システムの開発
  • 細胞・組織診断における採用バイオフォトニクス
• 市場抑制要因
  • 新しい治療法の採用に対する難色
• 市場機会
  • 非医療セグメントでのバイオフォトニクスの使用
  • ナノ技術の出現
• 市場課題
  • バイオフォトニクス技術の認知度不足

ポーターの5つの力：バイオフォトニクス市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、バイオフォトニクス市場の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競合を評価し、戦略的機会を探るための明確な手法を記載しています。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これら洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：バイオフォトニクス市場における外部からの影響の把握

外部マクロ環境要因は、バイオフォトニクス市場の業績力学を形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を記載しています。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析：バイオフォトニクス市場における競合情勢の把握

バイオフォトニクス市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、セグメント化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニングマトリックスバイオフォトニクス市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、バイオフォトニクス市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によりベンダーを明確かつ的確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨：バイオフォトニクス市場における成功への道筋を描く

バイオフォトニクス市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を検討することで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネス機会を活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目セグメントを網羅した市場の包括的な分析を提供しています。

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存セグメントにおける拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを記載しています。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発とイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています。

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、地域はどこか？

3.市場を形成する主要技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 高齢者の増加
    • 新しい光音響トモグラフィー（PAT）システムの開発
    • 細胞と組織診断における採用バイオフォトニクス
  • 抑制要因
    • 新しい治療法の導入に対する抵抗
  • 機会
    • 医療セグメント以外でのバイオフォトニクスの使用
    • ナノ技術の出現
  • 課題
    • バイオフォトニクス技術に対する認識不足
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治
  • 経済
  • 社会
  • 技術
  • 法律
  • 環境

第6章 バイオフォトニクス市場：用途別

• イントロダクション
• バイオセンサー
• イメージングの内部
• 光療法
• 顕微鏡検査
• シースルーイメージング
• スペクトロ分子
• 表面イメージング

第7章 バイオフォトニクス市場：最終用途別

• イントロダクション
• 医療診断
• 医療治療
• 非医療用途
• テストとコンポーネント

第8章 南北アメリカのバイオフォトニクス市場

• イントロダクション
• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第9章 アジア太平洋のバイオフォトニクス市場

• イントロダクション
• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第10章 欧州・中東・アフリカのバイオフォトニクス市場

• イントロダクション
• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第11章 競合情勢

• 市場シェア分析、2023年
• FPNVポジショニングマトリックス、2023年
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Becton, Dickinson and Company
• Carl Zeiss AG
• Hamamatsu Photonics K.K.
• Idex Corporation
• ImpediMed Limited
• Lumenis Be Ltd.
• LUMICKS Technologies B.V.
• Magritek
• Olympus Corporation
• Oxford Instruments Group
• PerkinElmer Inc.
• Photopharmics, Inc.
• Thermo Fisher Scientific Inc.
• THINKCYTE Inc.
• VivoSight by Michelson Diagnostics Ltd.

LIST OF FIGURES

• FIGURE 1. BIOPHOTONICS MARKET RESEARCH PROCESS
• FIGURE 2. BIOPHOTONICS MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL BIOPHOTONICS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL BIOPHOTONICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL BIOPHOTONICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL BIOPHOTONICS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL BIOPHOTONICS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL BIOPHOTONICS MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL BIOPHOTONICS MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. AMERICAS BIOPHOTONICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 11. AMERICAS BIOPHOTONICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. UNITED STATES BIOPHOTONICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 13. UNITED STATES BIOPHOTONICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. ASIA-PACIFIC BIOPHOTONICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. ASIA-PACIFIC BIOPHOTONICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. EUROPE, MIDDLE EAST & AFRICA BIOPHOTONICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. EUROPE, MIDDLE EAST & AFRICA BIOPHOTONICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. BIOPHOTONICS MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 19. BIOPHOTONICS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. BIOPHOTONICS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL BIOPHOTONICS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL BIOPHOTONICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL BIOPHOTONICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. BIOPHOTONICS MARKET DYNAMICS
• TABLE 7. GLOBAL BIOPHOTONICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL BIOPHOTONICS MARKET SIZE, BY BIOSENSORS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL BIOPHOTONICS MARKET SIZE, BY INSIDE IMAGING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL BIOPHOTONICS MARKET SIZE, BY LIGHT THERAPY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL BIOPHOTONICS MARKET SIZE, BY MICROSCOPY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL BIOPHOTONICS MARKET SIZE, BY SEE-THROUGH IMAGING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL BIOPHOTONICS MARKET SIZE, BY SPECTRO MOLECULAR, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL BIOPHOTONICS MARKET SIZE, BY SURFACE IMAGING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL BIOPHOTONICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL BIOPHOTONICS MARKET SIZE, BY MEDICAL DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL BIOPHOTONICS MARKET SIZE, BY MEDICAL THERAPEUTICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL BIOPHOTONICS MARKET SIZE, BY NON-MEDICAL APPLICATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL BIOPHOTONICS MARKET SIZE, BY TESTS & COMPONENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. AMERICAS BIOPHOTONICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 21. AMERICAS BIOPHOTONICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 22. AMERICAS BIOPHOTONICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 23. ARGENTINA BIOPHOTONICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 24. ARGENTINA BIOPHOTONICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 25. BRAZIL BIOPHOTONICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 26. BRAZIL BIOPHOTONICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 27. CANADA BIOPHOTONICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 28. CANADA BIOPHOTONICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 29. MEXICO BIOPHOTONICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 30. MEXICO BIOPHOTONICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 31. UNITED STATES BIOPHOTONICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 32. UNITED STATES BIOPHOTONICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 33. UNITED STATES BIOPHOTONICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 34. ASIA-PACIFIC BIOPHOTONICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 35. ASIA-PACIFIC BIOPHOTONICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 36. ASIA-PACIFIC BIOPHOTONICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 37. AUSTRALIA BIOPHOTONICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 38. AUSTRALIA BIOPHOTONICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 39. CHINA BIOPHOTONICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 40. CHINA BIOPHOTONICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 41. INDIA BIOPHOTONICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 42. INDIA BIOPHOTONICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 43. INDONESIA BIOPHOTONICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 44. INDONESIA BIOPHOTONICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 45. JAPAN BIOPHOTONICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 46. JAPAN BIOPHOTONICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 47. MALAYSIA BIOPHOTONICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 48. MALAYSIA BIOPHOTONICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 49. PHILIPPINES BIOPHOTONICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 50. PHILIPPINES BIOPHOTONICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 51. SINGAPORE BIOPHOTONICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 52. SINGAPORE BIOPHOTONICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 53. SOUTH KOREA BIOPHOTONICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 54. SOUTH KOREA BIOPHOTONICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 55. TAIWAN BIOPHOTONICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 56. TAIWAN BIOPHOTONICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 57. THAILAND BIOPHOTONICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 58. THAILAND BIOPHOTONICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 59. VIETNAM BIOPHOTONICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 60. VIETNAM BIOPHOTONICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 61. EUROPE, MIDDLE EAST & AFRICA BIOPHOTONICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 62. EUROPE, MIDDLE EAST & AFRICA BIOPHOTONICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 63. EUROPE, MIDDLE EAST & AFRICA BIOPHOTONICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 64. DENMARK BIOPHOTONICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 65. DENMARK BIOPHOTONICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 66. EGYPT BIOPHOTONICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 67. EGYPT BIOPHOTONICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 68. FINLAND BIOPHOTONICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 69. FINLAND BIOPHOTONICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 70. FRANCE BIOPHOTONICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 71. FRANCE BIOPHOTONICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 72. GERMANY BIOPHOTONICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 73. GERMANY BIOPHOTONICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 74. ISRAEL BIOPHOTONICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 75. ISRAEL BIOPHOTONICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 76. ITALY BIOPHOTONICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 77. ITALY BIOPHOTONICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 78. NETHERLANDS BIOPHOTONICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 79. NETHERLANDS BIOPHOTONICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 80. NIGERIA BIOPHOTONICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 81. NIGERIA BIOPHOTONICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 82. NORWAY BIOPHOTONICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 83. NORWAY BIOPHOTONICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 84. POLAND BIOPHOTONICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 85. POLAND BIOPHOTONICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 86. QATAR BIOPHOTONICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 87. QATAR BIOPHOTONICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 88. RUSSIA BIOPHOTONICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 89. RUSSIA BIOPHOTONICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 90. SAUDI ARABIA BIOPHOTONICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 91. SAUDI ARABIA BIOPHOTONICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 92. SOUTH AFRICA BIOPHOTONICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 93. SOUTH AFRICA BIOPHOTONICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 94. SPAIN BIOPHOTONICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 95. SPAIN BIOPHOTONICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 96. SWEDEN BIOPHOTONICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 97. SWEDEN BIOPHOTONICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 98. SWITZERLAND BIOPHOTONICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 99. SWITZERLAND BIOPHOTONICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 100. TURKEY BIOPHOTONICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 101. TURKEY BIOPHOTONICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 102. UNITED ARAB EMIRATES BIOPHOTONICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 103. UNITED ARAB EMIRATES BIOPHOTONICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 104. UNITED KINGDOM BIOPHOTONICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 105. UNITED KINGDOM BIOPHOTONICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 106. BIOPHOTONICS MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 107. BIOPHOTONICS MARKET, FPNV POSITIONING MATRIX, 2023

The Biophotonics Market was valued at USD 57.91 billion in 2023, expected to reach USD 63.14 billion in 2024, and is projected to grow at a CAGR of 9.12%, to USD 106.71 billion by 2030.

Biophotonics is an interdisciplinary field that involves the application of light-based technologies to study biological materials. It encompasses the development and use of photonic devices and techniques to analyze, image, and manipulate living tissues at the molecular and cellular levels. The necessity of biophotonics arises from its capability to provide non-invasive, high-resolution, and precise diagnostic and therapeutic solutions, significantly advancing medical research, diagnostics, and treatment. The primary applications include imaging systems like optical coherence tomography, microscopy, and spectroscopy, which play crucial roles in early disease detection, personalized medicine, and minimally invasive treatments. Key end-use sectors are healthcare, pharmaceuticals, biotechnology, and environmental monitoring, with healthcare being the principal driver due to rising demands for advanced diagnostic procedures and treatments.

In terms of market growth, biophotonics is influenced by technological advancements, increasing government funding for research, and heightened awareness of early disease detection techniques. The rise in chronic diseases and the aging global population further fuel the demand for innovative diagnostic and therapeutic solutions. Potential opportunities lie in expanding applications for telemedicine and remote diagnostics, driven by recent global health crises emphasizing the need for contactless healthcare solutions. However, challenges such as high costs of equipment, complex regulatory requirements, and lack of skilled professionals pose significant roadblocks. Additionally, rapid technological evolution necessitates constant investment in R&D, which may strain resources for smaller players.

Innovation in biophotonics can be directed towards cost-effective, portable diagnostic tools, and integration with artificial intelligence for enhanced data analysis and predictive diagnostics. Businesses should also explore nanoscale imaging and minimally invasive optical biosensors as potential growth areas. Collaborations between academia and industry could expedite technological advancements. The biophotonics market presents a dynamic and rapidly growing landscape, characterized by intense R&D activities and evolving technological paradigms. Companies can maintain a competitive edge by investing in emerging technologies, fostering cross-disciplinary collaborations, and tailoring solutions to meet the specific needs of healthcare providers and patients.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Biophotonics Market

The Biophotonics Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increase in geriatric populations
  • Development of novel Photoacoustic Tomography (PAT) System
  • Adoption biophotonics in cell and tissue diagnostics
• Market Restraints
  • Reluctance toward the adoption of new treatment practices
• Market Opportunities
  • Use of biophotonics in non-medical sectors
  • Emergence of nanotechnology
• Market Challenges
  • Lack of awareness of biophotonics technology

Porter's Five Forces: A Strategic Tool for Navigating the Biophotonics Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Biophotonics Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Biophotonics Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Biophotonics Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Biophotonics Market

A detailed market share analysis in the Biophotonics Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Biophotonics Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Biophotonics Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Biophotonics Market

A strategic analysis of the Biophotonics Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Biophotonics Market, highlighting leading vendors and their innovative profiles. These include Becton, Dickinson and Company, Carl Zeiss AG, Hamamatsu Photonics K.K., Idex Corporation, ImpediMed Limited, Lumenis Be Ltd., LUMICKS Technologies B.V., Magritek, Olympus Corporation, Oxford Instruments Group, PerkinElmer Inc., Photopharmics, Inc., Thermo Fisher Scientific Inc., THINKCYTE Inc., and VivoSight by Michelson Diagnostics Ltd..

Market Segmentation & Coverage

This research report categorizes the Biophotonics Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Application, market is studied across Biosensors, Inside Imaging, Light Therapy, Microscopy, See-Through Imaging, Spectro Molecular, and Surface Imaging.
• Based on End-Use, market is studied across Medical Diagnostics, Medical Therapeutics, Non-Medical Application, and Tests & Components.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increase in geriatric populations
    • 5.1.1.2. Development of novel Photoacoustic Tomography (PAT) System
    • 5.1.1.3. Adoption biophotonics in cell and tissue diagnostics
  • 5.1.2. Restraints
    • 5.1.2.1. Reluctance toward the adoption of new treatment practices
  • 5.1.3. Opportunities
    • 5.1.3.1. Use of biophotonics in non-medical sectors
    • 5.1.3.2. Emergence of nanotechnology
  • 5.1.4. Challenges
    • 5.1.4.1. Lack of awareness of biophotonics technology
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Biophotonics Market, by Application

• 6.1. Introduction
• 6.2. Biosensors
• 6.3. Inside Imaging
• 6.4. Light Therapy
• 6.5. Microscopy
• 6.6. See-Through Imaging
• 6.7. Spectro Molecular
• 6.8. Surface Imaging

7. Biophotonics Market, by End-Use

• 7.1. Introduction
• 7.2. Medical Diagnostics
• 7.3. Medical Therapeutics
• 7.4. Non-Medical Application
• 7.5. Tests & Components

8. Americas Biophotonics Market

• 8.1. Introduction
• 8.2. Argentina
• 8.3. Brazil
• 8.4. Canada
• 8.5. Mexico
• 8.6. United States

9. Asia-Pacific Biophotonics Market

• 9.1. Introduction
• 9.2. Australia
• 9.3. China
• 9.4. India
• 9.5. Indonesia
• 9.6. Japan
• 9.7. Malaysia
• 9.8. Philippines
• 9.9. Singapore
• 9.10. South Korea
• 9.11. Taiwan
• 9.12. Thailand
• 9.13. Vietnam

10. Europe, Middle East & Africa Biophotonics Market

• 10.1. Introduction
• 10.2. Denmark
• 10.3. Egypt
• 10.4. Finland
• 10.5. France
• 10.6. Germany
• 10.7. Israel
• 10.8. Italy
• 10.9. Netherlands
• 10.10. Nigeria
• 10.11. Norway
• 10.12. Poland
• 10.13. Qatar
• 10.14. Russia
• 10.15. Saudi Arabia
• 10.16. South Africa
• 10.17. Spain
• 10.18. Sweden
• 10.19. Switzerland
• 10.20. Turkey
• 10.21. United Arab Emirates
• 10.22. United Kingdom

11. Competitive Landscape

• 11.1. Market Share Analysis, 2023
• 11.2. FPNV Positioning Matrix, 2023
• 11.3. Competitive Scenario Analysis
• 11.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Becton, Dickinson and Company
• 2. Carl Zeiss AG
• 3. Hamamatsu Photonics K.K.
• 4. Idex Corporation
• 5. ImpediMed Limited
• 6. Lumenis Be Ltd.
• 7. LUMICKS Technologies B.V.
• 8. Magritek
• 9. Olympus Corporation
• 10. Oxford Instruments Group
• 11. PerkinElmer Inc.
• 12. Photopharmics, Inc.
• 13. Thermo Fisher Scientific Inc.
• 14. THINKCYTE Inc.
• 15. VivoSight by Michelson Diagnostics Ltd.